Passion for omega: Role of omega‑3 PUFAs during pregnancy for health of offspring

The basis of the normal course of pregnancy is optimal nutrition as one of the main elements of a healthy lifestyle. Numerous studies have established that long-chain omega 3 polyunsaturated fatty acids (PUFAs) have a variety of biological activities: anti-inflammatory, antioxidant, immunomodulatory, antiallergic, antithrombotic, antisclerotic, etc. Eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are necessary for the normal functioning of the body during pregnancy and intrauterine development of the child. Deficiency of omega 3 PUFAs leads to a disruption in the normal development and physiological formation of the structures of the brain, visual analyzer and the immune system of the fetus. The use of omega 3 PUFAs during pregnancy has a positive effect both on the neuropsychic state of the woman, preventing depression, and on the psychomotor development of the child, improving cognitive functions. It is important to ensure adequate intake of these compounds from food or dietary supplements to ensure the normal course and outcome of pregnancy.

[1]  E. Aparicio,et al.  Changes in fatty acid levels (saturated, monounsaturated and polyunsaturated) during pregnancy , 2021, BMC Pregnancy and Childbirth.

[2]  E. Aparicio,et al.  Maternal Factors Associated with Levels of Fatty Acids, Specifically n-3 PUFA during Pregnancy: ECLIPSES Study , 2021, Nutrients.

[3]  M. Szczuko,et al.  The Role of Arachidonic and Linoleic Acid Derivatives in Pathological Pregnancies and the Human Reproduction Process , 2020, International journal of molecular sciences.

[4]  A. Lichtenstein,et al.  EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study. , 2020, Atherosclerosis.

[5]  M. Szczuko,et al.  Inflammation with the participation of arachidonic (AA) and linoleic acid (LA) derivatives (HETEs and HODEs) is necessary in the course of a normal reproductive cycle and pregnancy. , 2020, Journal of reproductive immunology.

[6]  A. Duttaroy,et al.  Maternal dietary fatty acids and their roles in human placental development. , 2020, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  J. Strain,et al.  Relationships between seafood consumption during pregnancy and childhood and neurocognitive development: Two systematic reviews. , 2019, Prostaglandins, leukotrienes, and essential fatty acids.

[8]  Hoge,et al.  Imbalance between Omega-6 and Omega-3 Polyunsaturated Fatty Acids in Early Pregnancy Is Predictive of Postpartum Depression in a Belgian Cohort , 2019, Nutrients.

[9]  M. Timmermans,et al.  Low omega-3 index values and monounsaturated fatty acid levels in early pregnancy: an analysis of maternal erythrocytes fatty acids , 2018, Lipids in Health and Disease.

[10]  A. Sinha,et al.  Fish intake during pregnancy or infancy and allergic outcomes in children: A systematic review and meta‐analysis , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[11]  V. Jaddoe,et al.  Maternal plasma polyunsaturated fatty acid levels during pregnancy and childhood lipids and insulin levels , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  Sabine J. Roza,et al.  Maternal Fatty Acid Status During Pregnancy and Child Autistic Traits: The Generation R Study. , 2016, American journal of epidemiology.

[13]  A. Tardón,et al.  Maternal Consumption of Seafood in Pregnancy and Child Neuropsychological Development: A Longitudinal Study Based on a Population With High Consumption Levels. , 2016, American journal of epidemiology.

[14]  A. Nardi,et al.  Corrigendum to "Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy" [J. Affect. Disord. 152-154 (2014) 76-82]. , 2016, Journal of affective disorders.

[15]  K. Stormark,et al.  Docosahexaenoic Acid Status in Pregnancy Determines the Maternal Docosahexaenoic Acid Status 3-, 6- and 12 Months Postpartum. Results from a Longitudinal Observational Study , 2015, PloS one.

[16]  M. Zeegers,et al.  Potential programming of selected cardiometabolic risk factors at childhood by maternal polyunsaturated fatty acid availability in the MEFAB cohort. , 2015, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  U. Wahn,et al.  German National Consensus Recommendations on Nutrition and Lifestyle in Pregnancy by the ‘Healthy Start - Young Family Network' , 2014, Annals of Nutrition and Metabolism.

[18]  J. Sunyer,et al.  Fatty-acid composition of maternal and umbilical cord plasma and early childhood atopic eczema in a Spanish cohort , 2013, European Journal of Clinical Nutrition.

[19]  Rosalee S. Hellberg,et al.  Risk-Benefit Analysis of Seafood Consumption: A Review , 2012 .

[20]  Coralie Martin,et al.  Modulation of Fatty Acid Transport and Metabolism by Maternal Obesity in the Human Full-Term Placenta1 , 2012, Biology of reproduction.

[21]  R. Heddle,et al.  Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial , 2012, BMJ : British Medical Journal.

[22]  J. Heinrich,et al.  Effect of fatty acid status in cord blood serum on children's behavioral difficulties at 10 y of age: results from the LISAplus Study. , 2011, The American journal of clinical nutrition.

[23]  J. Penders,et al.  Maternal fatty acid status in pregnancy and childhood atopic manifestations: KOALA Birth Cohort Study , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  P. Haggarty.  Fatty acid supply to the human fetus. , 2010, Annual review of nutrition.

[25]  A. Hahn,et al.  Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children , 2010, European Journal of Pediatrics.

[26]  F. LaFerla,et al.  Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study , 2009, Neurochemistry International.

[27]  P. Marik,et al.  Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review , 2009, Clinical cardiology.

[28]  J. Dórea.  Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors. , 2007, American journal of perinatology.

[29]  B. Meyer,et al.  Longitudinal Assessment of Erythrocyte Fatty Acid Composition Throughout Pregnancy and Post Partum , 2007, Lipids.

[30]  J. Llobet,et al.  Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants. , 2007, Toxicology.

[31]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[32]  Section On Breastfeeding,et al.  Breastfeeding and the Use of Human Milk , 2005, Pediatrics.

[33]  A. Leaf,et al.  Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.